Impact of Twice-Daily Dosing of Insulin Glargine on Glycemic Outcomes in Hospitalized, Non-Critically Ill Patients
SN Comprehensive Clinical Medicine · 06.10.2026 · 8 (1)
DOI: 10.1007/s42399-026-02738-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift SN Comprehensive Clinical Medicine, online erschienen am 06.10.2026. Verfasst von Danielle Morris und 5 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Morris, D., Cutshall, B. T., Watson, H., Wolfe, E., Wentzler-Lara, L., & Wells, D. A. (2026). Impact of Twice-Daily Dosing of Insulin Glargine on Glycemic Outcomes in Hospitalized, Non-Critically Ill Patients. SN Comprehensive Clinical Medicine, 8(1). https://doi.org/10.1007/s42399-026-02738-5
Vancouver
Morris D, Cutshall BT, Watson H, Wolfe E, Wentzler-Lara L, Wells DA. Impact of Twice-Daily Dosing of Insulin Glargine on Glycemic Outcomes in Hospitalized, Non-Critically Ill Patients. SN Comprehensive Clinical Medicine. 2026;8(1). doi:10.1007/s42399-026-02738-5
BibTeX
@article{Morris2026,
author = {Morris, Danielle and Cutshall, B. Tate and Watson, Haley and Wolfe, Elizabeth and Wentzler-Lara, Leia and Wells, Drew A.},
title = {Impact of Twice-Daily Dosing of Insulin Glargine on Glycemic Outcomes in Hospitalized, Non-Critically Ill Patients},
journal = {SN Comprehensive Clinical Medicine},
year = {2026},
volume = {8},
number = {1},
doi = {10.1007/s42399-026-02738-5}
}
EUVIMED